Dov Elefant - Chief Financial Officer, Cellectar Biosciences, Inc

As of March 5, 2021


Dov Elefant Net Worth

  • Net worth is estimated to be at least $8.61M
  • Owns at least 11,755 units of Cellectar Biosciences, Inc stock

Dov Elefant Compensation at Cellectar Biosciences, Inc in 2020

  • Earned a $324,450 salary and a $126 bonus
  • Received a total compensation of $471,860

Dov Elefant Trading

  • Largest purchase of shares was 7,407 units , worth over $10K on December 28, 2020
  • In total has made about 5 transactions over 2 years
  • Usually trades in March, June, February, September and December, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Dov Elefant Mailing Address

  • Mailing address is Epicept Corporation 270 Sylvan Avenue Englewood Cliffs NJ 07632 NJ

Cellectar Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
James V. Caruso 2020 $475,000 $332,500 $208,740 - $1,016,240
James V. Caruso 2019 $450,500 $213,988 $269,972 - $934,460
Dov Elefant 2020 $324,450 $126,536 $20,874 - $471,860
Dov Elefant 2019 $97,500 $57,788 $157,149 - $312,437
Jarrod Longcor 2020 $353,245 $137,766 $83,496 - $574,507
Jarrod Longcor 2019 $333,250 $94,976 $111,077 - $539,303
Igor Grachev, M.D., Ph.D. 2020 $192,622 - $151,960 $239,494 $584,076
Igor Grachev, M.D., Ph.D. 2019 - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1279704/000110465921065536/tm2114944d1_def14a.htm

Cellectar Biosciences, Inc Insider Trading

  • The most recent transaction was 25,000 units bought on September 14, 2021 by Douglas J Swirsky worth over $26K
  • In the last 7 years, insiders at Cellectar Biosciences, Inc sold an estimated value of $1.22M and bought an estimated value of $3.87M
  • The most active traders are Awm Investment Company Inc,  James V Caruso, President and CEO,  and John Neis, Director
  • Insider trading is most common in June, with the busiest year in 2015

Cellectar Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1